In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...

Oncogenic YAP accelerates S-phase entry by shortening G1, leading to replication stress and sensitivity to CHK1 inhibition.

The Semaglutide peptide has emerged as a compelling subject in biochemical and physiological research due to its potential ...

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Researchers have identified a rare cell type and the signaling pathway behind how lung damage from toxins like wildfire smoke ...

Small, 3D-printed devices, designed to be implanted directly under the skin, could allow people with type 1 diabetes to ...

An engineered protein turns off the kind of immune cells most likely to damage tissue as part of Type-1 diabetes, hepatitis, ...